Cargando…

Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) affect 17–46% of Western countries, making coexistence with other liver diseases inevitable. We investigated the prevalence and clinical significance of NAFLD/NASH or the components of metabolic syndrome (Met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zachou, Kalliopi, Azariadis, Kalliopi, Lytvyak, Ellina, Snijders, Romée J.A.L.M., Takahashi, Atsushi, Gatselis, Nikolaos K., Robles, Mercedes, Andrade, Raul J., Schramm, Christoph, Lohse, Ansgar W., Tanaka, Atsushi, Drenth, Joost P.H., Montano-Loza, Aldo J., Dalekos, George N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339258/ https://www.ncbi.nlm.nih.gov/pubmed/37456672 http://dx.doi.org/10.1016/j.jhepr.2023.100778

Ejemplares similares

Patients with Haemoglobinopathies and Chronic Hepatitis C: A Real Difficult to Treat Population in 2016?
por: Zachou, Kalliopi, et al.
Publicado: (2017)

An Immunocompetent HIV-Negative Elderly Patient with Low-Grade Fever, Generalized Lymphadenopathy, Splenomegaly, and Acute Phase Response: Do Not Forget Castleman Disease
por: Azariadis, Kalliopi, et al.
Publicado: (2021)

Acute non-A, non-B, non-C hepatitis differences and similarities between hepatitis E virus infection and autoimmune hepatitis, with phylogenetic analysis of hepatitis E virus in humans and wild boars
por: Zachou, Kalliopi, et al.
Publicado: (2022)

Early Primary Biliary Cirrhosis: A New Association with Erythema Nodosum of Unknown Origin
por: Gatselis, Nikolaos K., et al.
Publicado: (2010)

Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis
por: Gatselis, Nikolaos K., et al.
Publicado: (2021)

Severe Pharyngodynia Followed by Migratory Polyarthritis and High Fever in Young Immigrants: Remember That Rheumatic Fever Is Still Relevant in 2020!
por: Azariadis, Kalliopi, et al.
Publicado: (2020)

Health-related quality of life in autoimmune hepatitis
por: Snijders, Romée JALM, et al.
Publicado: (2021)

Serum Cartilage Oligomeric Matrix Protein and Golgi Protein-73: New Diagnostic and Predictive Tools for Liver Fibrosis and Hepatocellular Cancer?
por: Gatselis, Nikolaos K., et al.
Publicado: (2021)

Vitamin D Is Associated with Clinical Outcomes in Patients with Primary Biliary Cholangitis
por: Ebadi, Maryam, et al.
Publicado: (2022)

Prognostic Significance of Severe Vitamin D Deficiency in Patients with Primary Sclerosing Cholangitis
por: Ebadi, Maryam, et al.
Publicado: (2023)

Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions
por: Georgiadou, Sarah, et al.
Publicado: (2019)

The changing epidemiology of hepatitis B in Greece
por: Rigopoulou, Eirini I., et al.
Publicado: (2021)

Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren’s Syndrome and Primary Biliary Cholangitis
por: Arvaniti, Pinelopi, et al.
Publicado: (2019)

Features and outcome of AIH patients without elevation of IgG
por: Hartl, Johannes, et al.
Publicado: (2020)

Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease
por: Zachou, Kalliopi, et al.
Publicado: (2004)

Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: a case series
por: Tsironi, Evangelia, et al.
Publicado: (2009)

Promyelocytic Leukemia Antigen Expression: a Histological Marker for Primary Biliary Cholangitis Diagnosis?
por: Papamichalis, Panagiotis A., et al.
Publicado: (2021)

First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients
por: Dalekos, George N., et al.
Publicado: (2022)

Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis
por: Laschtowitz, Alena, et al.
Publicado: (2021)

Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis
por: Dalekos, George N., et al.
Publicado: (2022)

FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease
por: Arvaniti, Pinelopi, et al.
Publicado: (2023)

Management of Patients with Liver Cirrhosis and Invasive Bladder Cancer: A Case-series
por: Zachos, Ioannis, et al.
Publicado: (2019)

Impact of genetic and environmental factors on autoimmune hepatitis
por: Zachou, Kalliopi, et al.
Publicado: (2021)

Safety and Efficacy of Transcatheter Arterial Chemoemboliazation in the Real-Life Management of Unresectable Hepatocellular Carcinoma
por: Mazioti, Argyro, et al.
Publicado: (2013)

Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis
por: Arvaniti, Pinelopi, et al.
Publicado: (2018)

Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients
por: Gatselis, Nikolaos K, et al.
Publicado: (2020)

The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders
por: Papamichalis, Panagiotis A, et al.
Publicado: (2007)

Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis
por: Arvaniti, Pinelopi, et al.
Publicado: (2020)

Low Serum Hepcidin in Patients with Autoimmune Liver Diseases
por: Lyberopoulou, Aggeliki, et al.
Publicado: (2015)

Concomitant Intake of Coca‐Cola to Manage the Drug–Drug Interaction Between Velpatasvir and Omeprazole Studied in Healthy Volunteers
por: van Seyen, Minou, et al.
Publicado: (2019)

Trends in obesity across Canada from 2005 to 2018: a consecutive cross-sectional population-based study
por: Lytvyak, Ellina, et al.
Publicado: (2022)

Plethora of Resistance Genes in Carbapenem-Resistant Gram-Negative Bacteria in Greece: No End to a Continuous Genetic Evolution
por: Tsilipounidaki, Katerina, et al.
Publicado: (2022)

Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER
por: Bernts, Lucas H. P., et al.
Publicado: (2019)

729. I Can CPO Clearing Now, the Iso is Gone
por: Schwartz, Danielle, et al.
Publicado: (2023)

Combination of vial culture and broad-range PCR for the diagnosis of spontaneous bacterial peritonitis: experience in a Greek tertiary care hospital
por: Malli, E., et al.
Publicado: (2018)

Everolimus and long acting octreotide as a volume reducing treatment of polycystic livers (ELATE): study protocol for a randomized controlled trial
por: Chrispijn, Melissa, et al.
Publicado: (2011)

A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?
por: Betzel, Bark, et al.
Publicado: (2014)

Perspective: improving vitamin D status in the management of COVID-19
por: Ebadi, Maryam, et al.
Publicado: (2020)

Management of Inflammatory Bowel Disease Patients With Clinical Care Pathways Reduces Emergency Department Utilization
por: Lytvyak, Ellina, et al.
Publicado: (2020)

Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management
por: Cnossen, Wybrich R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n9d96q1ol24q6s4qd8d8o89ckg